SB17170
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SB17170, covering 2025-11-19 to 2025-11-20. Get the full timeline:
Most recent: Clinical Trial Update: SB17170 Phase 1 Clinical Trial in Solid Tumors [Phase 1]